About
Critical Limb Ischemia Treatment
Areas of Focus
Categories
Medical MeasurementSurgical DeviceBiotech
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
492
By Phase
NA: 5
By Status
ACTIVE_NOT_RECRUITING: 3COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05313165Lead Sponsor
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NARecruiting
100 participants
Started: Dec 22, 2022 · Completed: May 1, 2027
NCT04304105Lead Sponsor
Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study
N/ACompleted
192 participants
Started: Feb 24, 2020 · Completed: Sep 12, 2022
NCT03807661Lead Sponsor
Percutaneous Deep Vein Arterialization Post-Market Study
NAActive, not recruiting
28 participants
Started: Dec 11, 2019 · Completed: Oct 9, 2024
NCT03970538Lead Sponsor
PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NAActive, not recruiting
105 participants
Started: Dec 6, 2019 · Completed: Feb 28, 2025
NCT03321552Lead Sponsor
PROMISE International
NAActive, not recruiting
35 participants
Started: Dec 15, 2017 · Completed: Dec 24, 2025
Locations (1)
Headquarters
San Jose, CA, United States
Map
Loading map...